Intratumoral expression of IL-12 and CD40 ligand (CD154) from plasmids generates antitumor responses that eliminate tumoral T regs. [PDF]
Ho GW +6 more
europepmc +1 more source
Genetic variant rs2243115 of the IL-12/IL-35 pathway contributes to the risk of coronary artery disease. [PDF]
Chen Q +5 more
europepmc +1 more source
Preclinical and clinical evaluation of intratumoral injection of an IL-12 expressing SKV-012 oncolytic virus for advanced solid tumors. [PDF]
Jiang Z +13 more
europepmc +1 more source
IL-12 minicircle delivery via extracellular vesicles as immunotherapy for bladder cancer. [PDF]
Wu Z +8 more
europepmc +1 more source
Mouse interleukin‐12 (IL‐12) p40 homodimer: a potent IL‐12 antagonist
European Journal of Immunology, 1995AbstractInterleukin‐12 (IL‐12) is a cytokine that has regulatory effects on T and natural killer (NK) cells and is composed of two disulfide‐bonded subunits, p40 and p35. It was recently reported that supernatants from cultures of mouse IL‐12 (moIL‐12) p40‐transfected COS cells could inhibit IL‐12‐dependent responses in vitro (Mattner, F., et al., Eur.
Gillessen Sommer, Silke +9 more
openaire +3 more sources
IL-12 ELISPOT ASSAYS TO DETECT AND ENUMERATE IL-12 SECRETING CELLS
Cytokine, 2000The cytokine IL-12 promotes Th(1)type immune responses and plays a key role in immune regulation. The complex nature of IL-12 hampered its detection without use of stimulants that might give less relevant information. To detect circulating IL-12 p40, we developed enzyme-linked immunospot (ELISPOT) assays that allow enumeration of IL-12 p40 secreting ...
Ozenci, V +4 more
openaire +4 more sources
Interleukin(IL)-12 is a protein that activates T cells and macrophages to kill tumor cells. However, despite this cytokine showing strong antitumor activity in preclinical settings, translation to patients has been slowed by toxic side effects, poor distribution to peripheral tissues, and improper dosing regimens.
Justin E, Markel +2 more
openaire +2 more sources
Delivery of IL-12 intranasally leads to reduced IL-12-mediated toxicity
International Immunopharmacology, 2003Interleukin-12 (IL-12) is a heterodimeric cytokine that enhances immune responses to bacterial, parasitic, and viral pathogens, and leads to tumor regression in animal models. For this reason, the use of IL-12 as a vaccine adjuvant and as a therapeutic agent for the treatment of cancer is being investigated.
Victor C, Huber +6 more
openaire +2 more sources
Prostaglandin E2 and Dexamethasone Inhibit IL-12 Receptor Expression and IL-12 Responsiveness
The Journal of Immunology, 1998AbstractRegulation of the factors governing IL-12R expression and IL-12 responsiveness has been shown to be important in the generation and stability of Th1- and Th2-type responses. In this regard, cytokines have been shown to have a prominent role in regulating IL-12R expression.
C Y, Wu +3 more
openaire +2 more sources
Interleukin 12 (IL-12) is a heterodimeric, multifunctional cytokine, the actions of which orchestrate activities of innate and adaptive immunity, partially due to a potent stimulation of IFN-γ production from T lymphocytes and natural killer (NK) cells.
Radoslaw Zagozdzon, Witold Lasek
openaire +2 more sources

